| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |